Leading the Way in Life Science Technologies

GEN Exclusives

More »

Market and Technology Analysis

More »
September 19, 2013

Stem Cells in the EU: Northern and Central Markets

Learn about stem cell institutions and opportunities in the U.K., Germany, the Netherlands, Belgium, and Sweden in this incisive report.

Stem Cells in the EU: Northern and Central Markets

The markets of northern and central Europe are ones to watch. [© beugdesign - Fotolia.com]

  • The focus of this GEN Market & Tech Analysis Report is to present some characteristics of selected Northern/Central EU markets vis-à-vis institutions, funding/opportunities in the broader stem cells field [and focusing as appropriate on stem cell banking, iPSCs, cord blood]. We present here data collected by our U.K. research team via primary market research from across Europe focusing on the following countries:

    • U.K.
    • Germany
    • The Netherlands
    • Belgium
    • Sweden

    Taken together, these data frame some of the characteristics, institutions as well as stem cell research opportunities in these countries. In a future GENReport, we will provide an analysis of the regulatory landscape in selected EU countries.

    CLICK HERE to download the PDF report.

Related content